“…In addition, T3 homologues differ from each other by the number of methyl groups in the chroman ring. T3 has been reported to have various activities, such as antioxidative, hypocholesterolemic and immunoregulatory activities [1,2]. It has also been reported to inhibit the proliferation of rat hepatoma dRLh-84 cells, normal mouse mammary epithelial cells, human breast carcinoma MCF-7, human leukemia HL-60 and murine B16 melanoma cells in vitro [3 -6], and skin cancer cells in vivo [6].…”